Health Archives - DrugGenius

News

UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference

SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced…

View Post

News

Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities

– Lumos Pharma expects to initiate its Phase 2b LUM-201 trial in Pediatric Growth Hormone Deficiency (PGHD) prior to the end of 2020 – Additional non-dilutive funds expected from anticipated…

View Post

News

Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610

CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host…

View Post

News

Anti-Inflammatory Drugs Market to Exhibit 9.3% CAGR by 2027; Owing to Rising Prevalence of Inflammatory Health Conditions: Fortune Business Insights™

Key Companies Covered in the Anti-Inflammatory Drugs Market Research Report are Novartis AG, AbbVie Inc., Biogen, Merck & Co., Inc., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson…

View Post

News

Anti-fungal Drugs Market to Reach USD 13.17 Billion by 2027; Increasing Number of Infectious Skin Disorders to Aid Growth: Fortune Business Insights™

Key Companies Covered in the Anti-Fungal Drugs Market Research Report Are Merck & Co., Inc., Leadiant Biosciences, Inc., GlaxoSmithKline plc., Bayer AG, Astellas Pharma Inc., Pfizer Inc., McKesson Medical-Surgical Inc.,…

View Post

News

NSAIDs Market to Reach USD 24.35 Billion by 2027; Surging Research on Selective Cyclooxygenase-2 Inhibitors to Boost Growth: Fortune Business Insights™

Key Companies Covered in the non-steroidal anti-inflammatory drugs (NSAIDs) market Research Report Are Pfizer Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Johnson & Johnson Services, Inc., Bayer AG, AstraZeneca, Zyla…

View Post

News

Neurodegenerative Diseases Drugs Market to Exhibit 7.2% CAGR till 2026; Rising Geriatric Population to Aid Growth: Fortune Business Insights™

Key Companies Covered in the Neurodegenerative Diseases Drugs Market Research Report Are Novartis AG, Biogen, Lundbeck A/S, Pfizer, Inc., Mitsubishi Tanabe Pharma Corporation, Hoffmann-La Roche Ltd., Orion Pharma, Merck &…

View Post

News

Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-004 in Parkinson’s Disease

Gene Therapy Program to Target the Regulation of the SNCA Gene of Alpha-Synuclein NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company…

View Post

News

RedHill Biopharma to Present at Jefferies Virtual Healthcare Conference

TEL-AVIV, Israel and RALEIGH, N.C., May 28, 2020 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that Mr. Dror Ben-Asher,…

View Post

News

Lumos Pharma to Participate in the Jefferies 2020 Healthcare Conference

AUSTIN, Texas, May 27, 2020 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced that the company will present at…

View Post